Sartorius | SRT3 - Sales Revenues


Sartorius reported EUR926.3M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 21.7M 4.09M Jun/2026
Dianthus Therapeutics USD 761K 298K Jun/2026
Ionis Pharmaceuticals USD 243M 25M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Moderna USD 1.31M 98.69M Sep/2026
Organon & Co USD 1.57B 10M Sep/2026
Revvity USD 729M 680K Sep/2026
Sartorius EUR 926.3M 14.5M Sep/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.75B 10M Sep/2026
Xeris Pharmaceuticals USD 92.1M 8.97M Jun/2026